Loading...
•
Mar 31, 2022
OrthoPediatrics Q1 2022 Earnings Report
OrthoPediatrics reported a revenue increase of 9% year-over-year, driven by growth in trauma and deformity, and scoliosis segments. The company increased its full-year revenue guidance for 2022.
Key Takeaways
OrthoPediatrics Corp. reported a 9% increase in revenue for Q1 2022, reaching $23.4 million compared to $21.5 million in Q1 2021. The company's U.S. revenue increased by 8%, while international revenue grew by 13%. Trauma and Deformity revenue increased by 13%, Scoliosis revenue increased by 1%, and Sports Medicine/Other revenue decreased by 4%. The company has increased its full year 2022 revenue guidance to $122 million to $125 million.
Total revenue reached $23.4 million, a 9% increase year-over-year.
U.S. revenue increased by 8%, while international revenue grew by 13%.
Trauma and Deformity revenue increased by 13%, Scoliosis revenue increased by 1%.
Full year 2022 revenue guidance increased to $122 million to $125 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
For full year 2022, the Company now expects its full year revenue to be in the range of $122 million to $125 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...